Finding a Private Clinic for Weight Loss Injections Near You

What the clinical evidence actually shows, and why it matters when choosing a provider

The reason private clinics now offer weight loss injections at scale is the quality of the trial data behind them. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, tirzepatide produced an average body-weight reduction of around 20–21% at the 15 mg dose over 72 weeks in adults with obesity. That translated into a NICE recommendation (TA1026) published in December 2024. Semaglutide's evidence base, built across the STEP programme, gave NICE enough to recommend Wegovy separately, and the regulators approved a higher 7.2 mg maintenance dose in early 2026.

Those approvals mean these medicines are well-characterised, their side-effect profiles, contraindications and monitoring requirements are established. Any clinic, physical or online, should be applying that evidence: titrating doses carefully, screening for conditions that rule out treatment, and following patients through the dose schedule. A brisk price list with no clinical review attached is a warning sign, not a perk. When you're comparing providers, the quality of the clinical oversight is the thing worth scrutinising, and our guide to what private clinic weight loss injections actually involve is a useful reference point for knowing what good looks like.

Treatment starts at 2.5 mg for tirzepatide, a dose chosen to help your system adjust rather than for any immediate therapeutic effect, the progression through higher doses happens in step with how you're tolerating the medicine, not on a fixed calendar. That titration process requires a prescriber to be involved at each stage, which is why the structure of the service matters as much as the molecule itself.

Physical clinic vs. regulated online service, what the difference actually means for you

Searching for a private weight loss injections clinic near you will surface both physical premises and online pharmacies. The legal and clinical requirements are identical. A GPhC-registered pharmacy must apply the same prescribing standards whether it sits on a high street or operates remotely, the Human Medicines Regulations 2012 draws no distinction.

The practical differences come down to convenience and speed. A physical appointment adds travel, waiting-room time, and often a longer booking lead time. A regulated online service can put your consultation in front of a prescriber the same day. At nume (sorry, at our pharmacy) a GPhC-registered Independent Prescriber reads every consultation personally; your application is not processed by software. Order by 12pm Monday to Friday and, once a prescriber has approved your treatment, the pen ships the same day via tracked DPD delivery, arriving free the next working day in plain packaging.

The one practical habit worth building right now: open the GPhC pharmacy register and search any provider you're considering. It takes under a minute. If the pharmacy isn't listed, it isn't authorised, and you should look elsewhere. Our GPhC premises registration number is 9012878, you can verify it directly.

NHS waiting lists and what private access looks like alongside them

Most people searching for a private clinic are doing so because the NHS route isn't accessible to them yet. NICE's phased NHS rollout for tirzepatide means access is currently restricted to adults with a BMI of 40 or above combined with four or more specific weight-related conditions; that cohort expanded to include BMI 35–39.9 from June 2026. Even within those criteria, commissioning varies by area and waiting lists for specialist weight management services can be long.

Private treatment operates outside those thresholds. The SmPC-licensed eligibility for private prescribing covers adults with a BMI of 30 or above, or 27 or above with at least one qualifying condition. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. That broader private eligibility is why many people who are clinically suitable for these medicines find private access is the realistic option right now, not a luxury one.

For context on what private treatment costs and what a legitimate price includes, the cost breakdown page covers this in detail. Headline prices vary significantly by dose, provider, and what's bundled in, consultation, prescription and aftercare are sometimes separate charges. Worth reading before you commit to any clinic.

Safety, side effects and what to watch for on private treatment

Whichever clinic or service you use, the safety picture for these medicines is the same. GI side effects (nausea, loose stools, constipation, reflux) are the most commonly reported, particularly in the first few weeks or after a dose increase. They're generally mild and settle as your body adjusts, but they're real, and a good provider will have discussed them with you before your first pen arrives.

More serious events are rare but important to know. In January 2026 the MHRA issued a Drug Safety Update flagging acute pancreatitis as an infrequent but potentially serious risk with GLP-1 medicines: severe stomach pain that spreads towards the back, with or without vomiting, warrants urgent medical attention. Any clinic (physical or online) should give you clear guidance on when to seek help. You can also report suspected side effects directly via the MHRA's Yellow Card scheme.

Women using oral contraceptives should be aware that tirzepatide may reduce pill absorption in the first four weeks of treatment and after each dose increase, an additional non-oral method is recommended during those windows. If you're pregnant, breastfeeding, or planning to conceive, these medicines aren't currently recommended. Under-18s are not a licensed group. A thorough prescriber will cover all of this at consultation; if a provider skips these questions, that's a signal to pause. For a fuller look at what private treatment involves, this overview covers the process from start to finish.